CINCINNATI--(BUSINESS WIRE)-- Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic ...
CINCINNATI--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first subject has been dosed in a phase 1b trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results